Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Features

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Michael O'Riordan

January 06, 2023

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Features

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Shelley Wood

July 20, 2020

News Features

Cardiology After COVID-19: Physicians Predict Lasting Change

Yael L. Maxwell

May 20, 2020

News Features

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

Michael O'Riordan

March 03, 2020

News Features

The Cancer Patient Needing PCI Poses Conundrums for Care

Shelley Wood

January 14, 2020

News Features

EXCEL Investigators Respond to Data Suppression Claims as Debate Erupts Online

Michael O'Riordan

December 12, 2019

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

News Features

Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option?

Shelley Wood

April 30, 2019

News Features

Top News in Coronary Artery Disease: 2018

Yael L. Maxwell

December 28, 2018

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Shelley Wood

October 22, 2018

News Features

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Michael O'Riordan

September 13, 2017

News Features

The Bioresorbable Stent Story So Far: What Promise? What Price?

Michael O'Riordan

August 17, 2016

Advertisement

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Cardiology After COVID-19: Physicians Predict Lasting Change

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

The Cancer Patient Needing PCI Poses Conundrums for Care

EXCEL Investigators Respond to Data Suppression Claims as Debate Erupts Online

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option?

Top News in Coronary Artery Disease: 2018

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

The Bioresorbable Stent Story So Far: What Promise? What Price?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content